Company Filing History:
Years Active: 2020-2022
Title: Bryce K Allen: Innovator in Pharmaceutical Modulation
Introduction
Bryce K Allen is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of the stimulator of interferon genes (STING) protein. With a total of 2 patents, his work is paving the way for advancements in therapeutic applications.
Latest Patents
Bryce's latest patents focus on oxoacridinyl acetic acid derivatives and their methods of use. These compounds, represented by Formula I, are capable of binding to and modulating the activity of the STING protein. The patents detail methods involving these compounds as effective modulators of STING, which could have important implications for treating various diseases.
Career Highlights
Throughout his career, Bryce has worked with several innovative companies, including Stingthera, Inc. and Silicon Swat, Inc. His experience in these organizations has allowed him to develop and refine his inventions, contributing to the advancement of pharmaceutical research.
Collaborations
Bryce has collaborated with notable individuals in his field, including Brian T Chamberlain and James M Rice. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in pharmaceutical modulation.
Conclusion
Bryce K Allen's contributions to the field of pharmaceutical sciences through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in the modulation of critical proteins, paving the way for future innovations.